Mutation detail:
| Mutation site | 5_31delLFLALITLATCELYHYQECVRGTTVLL |
| Virus | SARS-CoV-2 |
| Mutation level |
Amino acid level |
| Gene/protein/region type | ORF7a |
| Gene ID | 43740573 |
| Country | USA |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | - |
| Sample |
Human |
| Variants | - |
| Viral reference sequence | MN908947.3 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | ORF7a protein |
| Uniprot protein ID | - |
| Protein length | 121 amino acids |
| Protein description | - |
Literature information:
| Pubmed ID | 32357959 |
| Clinical information | No |
| Disease | - |
| Published year | 2020 |
| Journal | JOURNAL OF VIROLOGY |
| Title | An 81-Nucleotide Deletion in SARS-CoV-2 ORF7a Identified from Sentinel Surveillance in Arizona (January to March 2020) |
| Author | LaRinda A. Holland, Emily A. Kaelin, Rabia Maqsood, Bereket Estifanos, Lily I. Wu |
| Evidence | FIG 2 |